Article
FLT3 inhibitor-induced neutrophilic dermatosis.
Blood - 11 Jul 2013
Fathi Amir T, Le Long, Hasserjian Robert P, Sadrzadeh Hossein, Levis Mark, Chen Yi-Bin
Abstract excerpt
The FLT3-ITD mutation is associated with poor outcomes in acute myeloid leukemia. Multiple FMS-like tyrosine kinase 3 (FLT3)-inhibitors have been studied in clinical trials. Recently, potent FLT3 inhibition was shown to induce terminal differentiation of FLT3-mutant myeloblasts. In 3 patients who developed characteristic skin nodules on initiation of FLT3-inhibition, we conducted dermatopathologic evaluation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
